dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorAssisted Fertilizat Ctr
dc.contributorSapientiae Inst
dc.contributorCtr Human Reprod Prof Franco Jr
dc.date.accessioned2014-05-20T13:35:25Z
dc.date.accessioned2022-10-05T13:46:03Z
dc.date.available2014-05-20T13:35:25Z
dc.date.available2022-10-05T13:46:03Z
dc.date.created2014-05-20T13:35:25Z
dc.date.issued2009-01-01
dc.identifierReproductive Biomedicine Online. Cambridge: Reproductive Healthcare Ltd, v. 18, n. 1, p. 45-52, 2009.
dc.identifier1472-6483
dc.identifierhttp://hdl.handle.net/11449/12186
dc.identifier10.1016/S1472-6483(10)60423-3
dc.identifierWOS:000262709100007
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3888063
dc.description.abstractThe present study evaluated the effect of artificial oocyte activation (AOA) with calcium ionophore A23187 oil intracytoplasmic sperm injection (ICSI) cycles using spermatozoa from different sources. The 314 cycles evaluated were divided into three groups according to sperm origin, the ejaculated group (n = 92), the epididymal group (n = 82). and the testicular roup (n = 140). Each group was further split into experimental subgroups, depending oil whether or no AOA was performed. In additions the cycles of women younger than 36 years were evaluated separately. For each experimental group, ICSI outcomes were compared between subgroups. No significant difference was observed between subgroups for all sperm origin groups. When evaluating only the cycles of women younger than 36 years of age, AOA increased the percentage of high-quality embryos (74.5 versus 53.0%. P = 0.011) and the implantation rate (19.3 versus 10.5%, P = 0.0025) when it was used with ejaculated spermatozoa, and the percentage of high-quality embryos (64.4 versus 50.3%, P = 0.006) when epididymal spermatozoa were used. These results may suggest that both sperm maturity and oocyte quality play a role in oocyte activation. However. this study is to be continued to confirm these findings.
dc.languageeng
dc.publisherReproductive Healthcare Ltd
dc.relationReproductive BioMedicine Online
dc.relation2.967
dc.relation1,343
dc.rightsAcesso restrito
dc.sourceWeb of Science
dc.subjectcalcium
dc.subjectepididymis
dc.subjectICSI
dc.subjectspermatozoa
dc.subjecttesticle
dc.titleArtificial oocyte activation using calcium ionophore in ICSI cycles with spermatozoa from different sources
dc.typeArtigo


Este ítem pertenece a la siguiente institución